The Patent Finder

Pulmonary Surfactant Formulations and Methods for Promoting Mucus Clearance

Windtree Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 61/616,827, filed Mar 28, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,221,772Pulmonary Surfactant Formulations and Methods for Promoting Mucus Clearance
In force
 · High confidence
Windtree Therapeutics, Inc.In force
High confidence
US 8,748,396Lyophilization of Synthetic Liposomal Pulmonary Surfactant
In force
 · Medium confidence
Windtree Therapeutics, Inc.In force
Medium confidence
US 8,748,397Lyophilization of Synthetic Liposomal Pulmonary Surfactant
In force
 · Medium confidence
Windtree Therapeutics, Inc.In force
Medium confidence
US 9,554,999Lyophilization of Synthetic Liposomal Pulmonary Surfactant
In force
 · High confidence
Windtree Therapeutics, Inc.In force
High confidence
US 8,337,815Pulmonary Surfactant Formulations
Lapsed Dec 25, 2016 on the fee record
Ended Dec 25, 2016 · High confidence
Windtree Therapeutics, Inc.Lapsed Dec 25, 2016 on the fee recordEnded Dec 25, 2016
High confidence
US 7,582,312Methods to Produce Lung Surfactant Formulations via Lyophilization and Formulations and Uses Thereof
Lapsed Sep 1, 2017 on the fee record
Ended Sep 1, 2017 · High confidence
Windtree Therapeutics, Inc.Lapsed Sep 1, 2017 on the fee recordEnded Sep 1, 2017
High confidence
US 7,541,331Surfactant Treatment Regimen
Term ended
Term ended Jan 6, 2026 · High confidence
Windtree Therapeutics, Inc.Term endedTerm ended Jan 6, 2026
High confidence
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Windtree Therapeutics, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited